Addiction Medicine Certification Patient Safety & Risk Management 3

Question 1

Which tool is validated for assessing aberrant drug-related behaviors in patients receiving opioids for pain or addiction?

Accepted Answer

Current Opioid Misuse Measure (COMM)

Answer

The COMM is specifically validated to detect aberrant drug-related behaviors in patients on chronic opioid therapy.

Question 2

A pregnant patient with OUD refuses buprenorphine and requests rapid detoxification. What is the safest response?

Accepted Answer

Counsel that rapid detox is contraindicated in pregnancy due to fetal distress risk; strongly recommend MOUD

Answer

Medically supervised withdrawal in pregnancy carries high fetal risk; MOUD (methadone or buprenorphine) is the evidence-based standard of care.

Question 3

What is the purpose of an urine drug screen (UDS) in the context of addiction medicine patient safety?

Accepted Answer

To monitor treatment adherence, detect polysubstance use, and guide clinical decision-making

Answer

UDS is a clinical safety tool to confirm medication adherence, detect unreported substance use, and personalize treatment.

Question 4

A patient taking methadone is prescribed azithromycin for an infection. What safety concern must be addressed?

Accepted Answer

Both azithromycin and methadone prolong the QTc interval, increasing arrhythmia risk

Answer

Both agents prolong the QTc interval; concurrent use can cause dangerous arrhythmias including torsades de pointes.

Question 5

Which scenario represents an appropriate use of a treatment contract in addiction medicine?

Accepted Answer

To outline mutual expectations, patient responsibilities, and consequences within a therapeutic framework

Answer

Treatment contracts clarify expectations and responsibilities collaboratively, supporting engagement rather than serving as punitive instruments.

Addiction Medicine Certification Practice Test